Earnings calendar

Genmab A/S (GMAB) earnings: date, estimates, results and stock reactions

Over the last 12 reports the stock moved 3.9% on average (either way), rising 7 times and falling 5. EPS beat estimates 8 of 12 times; revenue 9 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q3 FY20262026-11-0536.8223.32+57.9%7.93B7.92B-1.4%
Q2 FY20262026-08-0631.7823.36+36.0%7.48B7.33B+5.7%
Q1 FY20262026-05-075.2710.10-47.8%5.69B5.87B-7.2%
Q4 FY20252026-02-173.1417.89-82.4%6.69B6.80B-2.5%
Q3 FY20252025-11-0641.7931.44+32.9%41.55B6.41B+0.5%
Q2 FY20252025-08-0734.6525.51+35.8%5.86B5.78B+0.4%
Q1 FY20252025-05-0820.2615.81+28.1%4.93B4.91B-3.3%
Q4 FY20242025-02-1258.8422.26+164.3%6.44B6.29B+8.6%

GMAB stock report · Earnings calendar